TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 32.09%18.86B | -4.57%31.68B | -15.87%14.28B | -11.47%33.2B | -14.43%16.97B | -1.33%37.5B | 5.14%19.83B | 0.40%38B | 21.12%18.86B | 45.95%37.85B |
Operating income | 32.09%18.86B | -4.57%31.68B | -15.87%14.28B | -11.47%33.2B | -14.43%16.97B | -1.33%37.5B | 5.14%19.83B | 0.40%38B | 21.12%18.86B | 45.95%37.85B |
Cost of sales | -28.53%-15.61B | -1.88%-27.09B | 9.68%-12.15B | 7.54%-26.59B | 9.66%-13.45B | 1.85%-28.76B | 1.98%-14.89B | 2.64%-29.3B | -19.48%-15.19B | -43.20%-30.1B |
Operating expenses | -28.53%-15.61B | -1.88%-27.09B | 9.68%-12.15B | 7.54%-26.59B | 9.66%-13.45B | 1.85%-28.76B | 1.98%-14.89B | 2.64%-29.3B | -19.48%-15.19B | -43.20%-30.1B |
Gross profit | 52.37%3.25B | -30.50%4.59B | -39.51%2.13B | -24.40%6.6B | -28.79%3.52B | 0.44%8.74B | 34.55%4.95B | 12.22%8.7B | 28.36%3.68B | 57.75%7.75B |
Selling expenses | 5.84%-226.07M | -17.66%-415.1M | -46.91%-240.09M | -28.70%-352.79M | -5.10%-163.43M | 12.56%-274.11M | -14.34%-155.5M | -12.51%-313.48M | -4.01%-136M | -32.76%-278.62M |
Administrative expenses | -23.04%-563.46M | -8.76%-1.01B | -4.56%-457.94M | -22.57%-928.58M | -16.11%-437.99M | -5.43%-757.59M | -13.13%-377.23M | -10.48%-718.57M | -29.54%-333.43M | -49.90%-650.41M |
Research and development expenses | -21.88%-1.47B | 8.45%-2.57B | 17.94%-1.2B | -6.10%-2.8B | -11.16%-1.47B | -5.73%-2.64B | -23.67%-1.32B | -13.11%-2.5B | -29.21%-1.07B | -62.17%-2.21B |
Impairment and provision | -379.94%-26.96M | -111.08%-22.31M | 28.95%-5.62M | -103.98%-10.57M | 45.45%-7.91M | -142.41%-5.18M | -97.76%-14.49M | 212.10%12.22M | 52.83%-7.33M | -183.02%-10.9M |
-Other impairment is provision | -379.94%-26.96M | -111.08%-22.31M | 28.95%-5.62M | -103.98%-10.57M | 45.45%-7.91M | -142.41%-5.18M | -97.76%-14.49M | 212.10%12.22M | 52.83%-7.33M | -183.02%-10.9M |
Special items of operating profit | -1.18%564.82M | 139.59%1.21B | 61.99%571.58M | -36.09%504.25M | 32.17%352.85M | 13.10%789.01M | 132.90%266.97M | 240.50%697.65M | -26.24%114.63M | 17.72%204.89M |
Operating profit | 92.32%1.53B | -40.78%1.78B | -55.85%793.71M | -48.45%3.01B | -46.26%1.8B | -0.52%5.85B | 48.94%3.35B | 22.27%5.88B | 25.54%2.25B | 56.19%4.81B |
Financing cost | -18.06%-272.69M | -53.33%-449.15M | -101.02%-230.97M | -27.22%-292.94M | 1.30%-114.9M | 1.49%-230.25M | 5.00%-116.42M | 6.67%-233.74M | 3.05%-122.54M | -23.90%-250.44M |
Share of profits of associates | -117.33%-5.05M | 475.52%22.52M | 2,951.52%29.14M | -131.55%-6M | 4,675.00%955K | 94,935.00%19.01M | 110.70%20K | 100.36%20K | 91.47%-187K | 76.87%-5.5M |
Earning before tax | 110.97%1.25B | -49.98%1.36B | -64.85%591.88M | -51.82%2.71B | -47.85%1.68B | -0.14%5.63B | 52.06%3.23B | 24.01%5.64B | 27.87%2.12B | 59.59%4.55B |
Tax | -3.54%-137.17M | 13.70%-207.83M | 56.55%-132.49M | 58.40%-240.83M | 41.63%-304.92M | 17.60%-578.97M | -50.40%-522.34M | -32.33%-702.63M | -52.22%-347.3M | -56.81%-530.97M |
After-tax profit from continuing operations | 141.96%1.11B | -53.51%1.15B | -66.68%459.39M | -51.06%2.47B | -49.06%1.38B | 2.34%5.06B | 52.39%2.71B | 22.91%4.94B | 23.99%1.78B | 59.96%4.02B |
Earning after tax | 141.96%1.11B | -53.51%1.15B | -66.68%459.39M | -51.06%2.47B | -49.06%1.38B | 2.34%5.06B | 52.39%2.71B | 22.91%4.94B | 23.99%1.78B | 59.96%4.02B |
Minority profit | 43.41%32.52M | -23.28%50.91M | 8.31%22.68M | -2.29%66.35M | 12.26%20.94M | -0.81%67.91M | -31.19%18.65M | 143.83%68.46M | 2,064.94%27.11M | 28.75%28.08M |
Profit attributable to shareholders | 147.07%1.08B | -54.34%1.1B | -67.84%436.71M | -51.73%2.41B | -49.48%1.36B | 2.39%4.99B | 53.68%2.69B | 22.06%4.87B | 22.21%1.75B | 60.24%3.99B |
Basic earnings per share | 147.66%0.9904 | -54.27%1.0072 | -67.78%0.3999 | -51.75%2.2026 | -49.52%1.2413 | 2.41%4.5652 | 53.85%2.4592 | 22.20%4.4578 | 22.21%1.5984 | 60.06%3.6481 |
Diluted earnings per share | 147.83%0.9901 | -54.29%1.0063 | -67.79%0.3995 | -51.71%2.2015 | -49.49%1.2403 | 2.42%4.5593 | 53.83%2.4554 | 22.23%4.4514 | 22.17%1.5962 | 60.26%3.6419 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.